[IART] Integra LifeSciences Holdings Corporation

Overview

Type of security: Stock

Sector: Capital Goods

Industry: Biotechnology: Laboratory Analytical Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 85.91 Change: 0.57 (0.67%)
Ext. hours: Change: 0 (0%)

chart IART

Refresh chart

Strongest Trends Summary For IART

IART is in the medium-term down -16% in 1 month and down -30% in 3 months. In the long-term up 213% in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. Its orthopedics products include specialty metal implants for surgery of the extremities, shoulder, and spine; orthobiologic products for repair and grafting of bone, including demineralized bone products, collagen ceramic matrices, and synthetic bone grafting solutions; dermal regeneration products and tissue-engineered wound dressings; and nerve and tendon repair products. The company also offers spinal fusion technologies comprising integrated interbody fusion devices, minimally invasive solutions, and deformity correction products; and neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devi

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 1% Sales Growth - Q/Q-7.34% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA2.59% ROE5.84% ROI3.02%
Current Ratio4.12 Quick Ratio2.28 Long Term Debt/Equity1.55 Debt Ratio0.18
Gross Margin62.28% Operating Margin7.77% Net Profit Margin4.24% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities30.45 M Cash From Investing Activities-18.74 M Cash From Operating Activities49.74 M Gross Profit157.54 M
Net Profit5 M Operating Profit13.95 M Total Assets1.64 B Total Current Assets608.25 M
Total Current Liabilities155.75 M Total Debt654.14 M Total Liabilities926.17 M Total Revenue244.08 M
Technical Data
High 52 week67.23 Low 52 week46.55 Last close46.57 Last change-2.45%
RSI15.2 Average true range1.68 Beta0.65 Volume390.34 K
Simple moving average 20 days-8.72% Simple moving average 50 days-15.96% Simple moving average 200 days-22.19%
Performance Data
Performance Week-6.49% Performance Month-14.2% Performance Quart-26.04% Performance Half-30.16%
Performance Year-6.8% Performance Year-to-date-2.7% Volatility daily1.66% Volatility weekly3.72%
Volatility monthly7.62% Volatility yearly26.39% Relative Volume322.8% Average Volume562.8 K
New High New Low

News

2019-01-15 08:05:53 | See what the IHS Markit Score report has to say about Integra LifeSciences Holdings Corp.

2019-01-11 09:39:02 | Integra LifeSciences Unveils Titan RSS-S, Widens Portfolio

2019-01-10 07:25:00 | Recent Analysis Shows T-Mobile US, Thor Industries, Integra LifeSciences, Diplomat Pharmacy, Tile Shop Hldgs, and Compass Diversified Market Influences — Renewed Outlook, Key Drivers of Growth

2019-01-10 06:30:00 | Integra LifeSciences Launches Integra® Titan™ Reverse Shoulder System-S

2019-01-09 09:15:02 | Integra IART Rises 5% on Robust Preliminary Q4 Results

2019-01-09 09:07:46 | Should We Worry About Integra LifeSciences Holdings Corporation’s NASDAQ:IART P/E Ratio?

2019-01-09 08:07:07 | See what the IHS Markit Score report has to say about Integra LifeSciences Holdings Corp.

2019-01-09 07:00:00 | Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director

2019-01-08 07:01:00 | Integra LifeSciences Announces Agreement with Consortium of Focused Orthopedists to Develop a Short Stem and Stemless Shoulder System

2019-01-08 07:00:00 | Integra LifeSciences Announces Preliminary Fourth Quarter 2018 Financial Results

2018-12-24 09:22:02 | Integra Rides on Global Prospects, Hurt by Escalating Costs

2018-12-22 03:49:29 | Do Hedge Funds Love Integra Lifesciences Holdings Corp IART?

2018-12-18 16:01:00 | Integra LifeSciences to Present at the 37th Annual J.P. Morgan Healthcare Conference

2018-12-12 12:13:00 | How Does Medtronic’s Restorative Therapies & Diabetes Group Look?

2018-11-30 09:31:02 | Integra IART Down 2.2% Since Last Earnings Report: Can It Rebound?

2018-11-28 10:02:03 | Integra's IART Margin Pressure Hurts, Global Prospects High

2018-11-20 16:01:00 | Integra® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery

2018-11-12 16:01:00 | Integra LifeSciences Appoints Eric Schwartz, Corporate Vice President, General Counsel and Secretary

2018-11-10 08:07:32 | See what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.

2018-11-08 16:01:00 | Integra LifeSciences to participate in Healthcare Conferences in November 2018

2018-11-07 08:15:00 | Detailed Research: Economic Perspectives on Integra LifeSciences, American Assets Trust, Teekay Offshore Partners, Acacia Communications, Piedmont Office Realty Trust, and Macerich — What Drives Growth in Today's Competitive Landscape

2018-11-05 08:07:23 | See what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.

2018-11-01 12:20:04 | Integra IART Q3 Earnings Meet Estimates, Revenue View Dips

2018-10-31 16:38:47 | Edited Transcript of IART earnings conference call or presentation 31-Oct-18 12:30pm GMT

2018-10-31 07:30:11 | Integra LifeSciences IART Matches Q3 Earnings Estimates

2018-10-31 06:14:31 | Integra: 3Q Earnings Snapshot

2018-10-31 06:00:00 | Integra LifeSciences Reports Third Quarter 2018 Financial Results

2018-10-30 09:40:01 | Medical Product Stock Q3 Earnings on Oct 31: BAX, MASI & More

2018-10-24 10:31:02 | Integra LifeSciences IART Q3 Earnings Preview: What to Watch Ahead of the Release

2018-10-16 08:07:27 | See what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.

2018-10-13 08:06:59 | See what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.

2018-10-11 16:05:00 | Integra LifeSciences to Host Third Quarter 2018 Earnings Results Conference Call on October 31, 2018

2018-10-11 08:06:59 | See what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.

2018-10-04 08:00:00 | New Research Coverage Highlights Harley-Davidson, Ritchie Bros. Auctioneers, Devon Energy, Dunkin' Brands Group, Acco Brands, and Integra LifeSciences — Consolidated Revenues, Company Growth, and Expectations for 2018

2018-09-19 16:01:00 | Integra LifeSciences to participate in the Cantor Global Healthcare Conference

2018-09-11 10:29:02 | Integra Lifesciences Picked for Healogics iSupply Program

2018-09-10 16:01:00 | Integra LifeSciences Selected for Healogics iSupply? Program

2018-08-24 10:24:02 | Why Is Integra IART Down 2.7% Since Last Earnings Report?

2018-08-21 15:41:23 | Are Integra LifeSciences Holdings Corporation’s NASDAQ:IART Interest Costs Too High?

2018-08-18 08:07:19 | See what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.

2018-08-15 16:01:00 | Integra LifeSciences to Present at Healthcare Conferences in September 2018

2018-08-15 08:07:34 | See what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.

2018-08-14 11:45:03 | Integra LifeSciences Codman Arm Strong, Competition Rife

2018-08-11 08:07:01 | See what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.

2018-08-08 08:07:38 | See what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.

2018-07-26 09:51:01 | Integra IART Reports In-Line Q2 Earnings, Tapers View

2018-07-25 17:13:09 | Edited Transcript of IART earnings conference call or presentation 25-Jul-18 12:30pm GMT

2018-07-25 08:41:11 | Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile

2018-07-25 06:30:00 | Integra LifeSciences Holdings Corporation to Host Earnings Call

2018-07-25 06:08:15 | Integra: 2Q Earnings Snapshot